| Identification | Back Directory | [Name]
tert-butyl((4-bromo-5-cyano-1-methyl-1H-pyrazol-3-yl)methyl)(methyl)carbamate | [CAS]
1454848-24-8 | [Synonyms]
EOS-60599
tert-butyl((4-bromo-5-cyano-1-methyl-1H-pyrazol-3-yl)methyl)(methyl)carbamate
TERT-BUTYL N-[(4-BROMO-5-CYANO-1-METHYL-1H-PYRAZOL-3-YL)METHYL]-N-METHYLCARBAMATE
Carbamic acid, N-[(4-bromo-5-cyano-1-methyl-1H-pyrazol-3-yl)methyl]-N-methyl-, 1,1-dimethylethyl ester | [Molecular Formula]
C12H17BrN4O2 | [MDL Number]
MFCD30803236 | [MOL File]
1454848-24-8.mol | [Molecular Weight]
329.19 |
| Hazard Information | Back Directory | [Uses]
tert-butyl((4-bromo-5-cyano-1-methyl-1H-pyrazol-3-yl)methyl)(methyl)carbamate is a pharmaceutical intermediate compound that can be used in the synthetic anticancer prescription drug Lorlatinib. Lorlatinib is a drug used in the treatment of non-small cell lung cancer caused by adult non-small cell lung cancer (NSCLC) caused by an unusual mesenchymal lymphoma. |
|
|